News tagged with nexavar
Related topics: cancer drugs , drug
Sorafenib
Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar), is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primary liver cancer (hepatocellular carcinoma).
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
India rejects Bayer plea against cheap cancer drug (Update)
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting ...
Medications
Mar 05, 2013 |
5 / 5 (4) |
3
Bayer vows to fight for patent on anti-cancer drug in India
German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.
Medications
Mar 04, 2013 |
not rated yet |
0
Temple researchers show targeted cancer drug may stunt heart's ability to repair itself
Scientists for the first time have evidence showing how a widely used type of "targeted" cancer drug can be dangerous to the heart.
Cardiology
Nov 06, 2012 |
4 / 5 (2) |
0
|
Bayer 'disappointed' after losing India patent fight
Pharmaceutical giant Bayer AG on Wednesday said it was "disappointed" with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and lung cancer.
Medications
Sep 26, 2012 |
not rated yet |
0
Bayer challenges India cancer drug ruling
German pharmaceutical giant Bayer AG has challenged a ground-breaking Indian ruling that allowed a local firm to produce a vastly cheaper copy of its patented drug for kidney and liver cancer.
Medications
May 06, 2012 |
5 / 5 (1) |
0
Indian drug giant Cipla slashes cancer drug prices
Indian drugs giant Cipla said Friday it has slashed by up to 76 percent prices of generic medicines used to treat brain, lung and kidney cancer in what the company called a "humanitarian move".
Medications
May 04, 2012 |
4.9 / 5 (9) |
0
India licenses generic copy of patented Bayer drug
(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.
Medications
Mar 12, 2012 |
5 / 5 (4) |
0
Three 'targeted' cancer drugs raise risk of fatal side effects
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber Cancer Institute. They added that ...
Cancer
Feb 06, 2012 |
5 / 5 (1) |
0
|
FDA panel backs Pfizer drug for kidney cancer
(AP) -- A panel of advisers to the Food and Drug Administration voted Wednesday that the benefits of a Pfizer kidney cancer drug outweigh its risks, according to a company spokeswoman.
Medications
Dec 07, 2011 |
not rated yet |
0
